330 related articles for article (PubMed ID: 38222069)
41. Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats.
Pokrzywinski KL; Biel TG; Rosen ET; Bonanno JL; Aryal B; Mascia F; Moshkelani D; Mog S; Rao VA
Biol Sex Differ; 2018 Jun; 9(1):25. PubMed ID: 29907135
[TBL] [Abstract][Full Text] [Related]
42. A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect.
Bjørnstad R; Reiten IN; Knudsen KS; Schjøtt J; Herfindal L
Int J Pharm; 2022 Dec; 629():122379. PubMed ID: 36370997
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms.
Rahimi O; Kirby J; Varagic J; Westwood B; Tallant EA; Gallagher PE
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H883-H894. PubMed ID: 32083974
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
45. Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption.
Ahmad N; Ullah A; Chu P; Tian W; Tang Z; Sun Z
Chem Biol Interact; 2022 Sep; 365():110028. PubMed ID: 35921947
[TBL] [Abstract][Full Text] [Related]
46. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity.
Motlagh PE; Novin AG; Ghahari F; Nikzad A; Khoshandam M; Mardani S; Khanbabaei H; Farsinejad A; Sathyapalan T; Sahebkar A; Pourghadamyari H
Adv Exp Med Biol; 2021; 1328():143-153. PubMed ID: 34981476
[TBL] [Abstract][Full Text] [Related]
48. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
49. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
Seymour L; Bramwell V; Moran LA
Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
[TBL] [Abstract][Full Text] [Related]
50. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
51. Potential role of the apelin-APJ pathway in sex-related differential cardiotoxicity induced by doxorubicin in mice.
Desai VG; Azevedo-Pouly A; Vijay V; Phanavanh B; Moland CL; Han T; Revollo J; Aryal B; Rao VA; Fuscoe JC
J Appl Toxicol; 2023 Apr; 43(4):557-576. PubMed ID: 36227756
[TBL] [Abstract][Full Text] [Related]
52. sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats.
Hu Y; Guo Z; Lu J; Wang P; Sun S; Zhang Y; Li J; Zheng Q; Guo K; Wang J; Jiang J; Liu P
Arch Toxicol; 2019 Feb; 93(2):533-546. PubMed ID: 30377735
[TBL] [Abstract][Full Text] [Related]
53. Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity.
Zhan H; Aizawa K; Sun J; Tomida S; Otsu K; Conway SJ; Mckinnon PJ; Manabe I; Komuro I; Miyagawa K; Nagai R; Suzuki T
Cardiovasc Res; 2016 May; 110(1):85-95. PubMed ID: 26862121
[TBL] [Abstract][Full Text] [Related]
54. Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway.
Liang L; Tu Y; Lu J; Wang P; Guo Z; Wang Q; Guo K; Lan R; Li H; Liu P
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028181
[TBL] [Abstract][Full Text] [Related]
55. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
56. Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.
Xi L; Zhu SG; Das A; Chen Q; Durrant D; Hobbs DC; Lesnefsky EJ; Kukreja RC
Nitric Oxide; 2012 May; 26(4):274-84. PubMed ID: 22484629
[TBL] [Abstract][Full Text] [Related]
57. Mitigation of doxorubicin-induced cardiotoxicity with an H
Hu Q; Yammani RD; Brown-Harding H; Soto-Pantoja DR; Poole LB; Lukesh JC
Redox Biol; 2022 Jul; 53():102338. PubMed ID: 35609400
[TBL] [Abstract][Full Text] [Related]
58. Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin.
Miranda CJ; Makui H; Soares RJ; Bilodeau M; Mui J; Vali H; Bertrand R; Andrews NC; Santos MM
Blood; 2003 Oct; 102(7):2574-80. PubMed ID: 12805055
[TBL] [Abstract][Full Text] [Related]
59. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity.
Abushouk AI; Ismail A; Salem AMA; Afifi AM; Abdel-Daim MM
Biomed Pharmacother; 2017 Jun; 90():935-946. PubMed ID: 28460429
[TBL] [Abstract][Full Text] [Related]
60. Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Dhakal I; Wei J; Stone A; Carter W; Owen A; Klimberg VS
Oncol Res; 2017 Sep; 25(8):1223-1229. PubMed ID: 28256194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
